Study Stopped
The study was terminated by the Principal Investigator's to redesign it using more efficient processes.
Gastroesophageal Reflux Disease Prospective Registry
GERD
1 other identifier
observational
744
1 country
1
Brief Summary
The purpose of this registry is to evaluate information to determine which operations and treatments for gastroesophageal reflux disease or similar diseases of the stomach, esophagus or digestive tract are providing the most benefit including the long-term effects of treatment (or no treatment) and the progression of the disease over time.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2014
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2014
CompletedFirst Submitted
Initial submission to the registry
May 7, 2015
CompletedFirst Posted
Study publicly available on registry
June 24, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2024
CompletedMay 22, 2025
May 1, 2025
10.7 years
May 7, 2015
May 21, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Postoperative patient reported sign and symptoms
Patient reported signs and symptoms as reported in Reflux scale and GERD questionnaire.
Up to 10 years after surgery
Study Arms (1)
Diagnosed with GERD
Collect data on GERD patients
Interventions
Eligibility Criteria
Patients with diagnosis of GERD or a similar disease of the stomach, esophagus or digestive tract.
You may qualify if:
- \- Any patient undergoing anti-reflux surgery
You may not qualify if:
- \- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Baylor Research University Medical Center
Dallas, Texas, 75246, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Steven Leeds, MD
Baylor Health Care System
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 10 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 7, 2015
First Posted
June 24, 2015
Study Start
January 1, 2014
Primary Completion
September 1, 2024
Study Completion
September 1, 2024
Last Updated
May 22, 2025
Record last verified: 2025-05